PLoS ONE (Jan 2017)

Age-Associated ALU Element Instability in White Blood Cells Is Linked to Lower Survival in Elderly Adults: A Preliminary Cohort Study.

  • R Garrett Morgan,
  • Massimo Venturelli,
  • Cole Gross,
  • Cantor Tarperi,
  • Federico Schena,
  • Carlo Reggiani,
  • Fabio Naro,
  • Anna Pedrinolla,
  • Lucia Monaco,
  • Russell S Richardson,
  • Anthony J Donato

DOI
https://doi.org/10.1371/journal.pone.0169628
Journal volume & issue
Vol. 12, no. 1
p. e0169628

Abstract

Read online

ALU element instability could contribute to gene function variance in aging, and may partly explain variation in human lifespan.To assess the role of ALU element instability in human aging and the potential efficacy of ALU element content as a marker of biological aging and survival.Preliminary cohort study.We measured two high frequency ALU element subfamilies, ALU-J and ALU-Sx, by a single qPCR assay and compared ALU-J/Sx content in white blood cell (WBCs) and skeletal muscle cell (SMCs) biopsies from twenty-three elderly adults with sixteen healthy sex-balanced young adults; all-cause survival rates of elderly adults predicted by ALU-J/Sx content in both tissues; and cardiovascular disease (CVD)- and cancer-specific survival rates of elderly adults predicted by ALU-J/Sx content in both tissues, as planned subgroup analyses.We found greater ALU-J/Sx content variance in WBCs from elderly adults than young adults (P < 0.001) with no difference in SMCs (P = 0.94). Elderly adults with low WBC ALU-J/Sx content had worse four-year all-cause and CVD-associated survival than those with high ALU-J/Sx content (both P = 0.03 and hazard ratios (HR) ≥ 3.40), while WBC ALU-J/Sx content had no influence on cancer-associated survival (P = 0.42 and HR = 0.74). SMC ALU-J/Sx content had no influence on all-cause, CVD- or cancer -associated survival (all P ≥ 0.26; HR ≤ 2.07).These initial findings demonstrate that ALU element instability occurs with advanced age in WBCs, but not SMCs, and imparts greater risk of all-cause mortality that is likely driven by an increased risk for CVD and not cancer.